文献速递慢性静脉疾病

逆行给药超声引导下静脉内微泡沫化学消融治疗浅表静脉功能不全

Retrograde administration of ultrasound-guided endovenous microfoam chemical ablation for the treatment of superficial venous insufficiency.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2018-01-01

研究纳入2015年3月至2017年6月间250例C2-C6慢性静脉功能不全的症状性患者,接受1%聚多卡醇微泡沫逆行超声引导治疗,随访16±7个月。94.4%患者静脉瓣膜反流完全消除且症状改善,55例(22.0%)需计划性二次治疗,轻微不良事件包括无症状深静脉血栓2例等。

要点

  • 1%聚多卡醇微泡沫逆行超声引导治疗C2-C6慢性静脉功能不全,94.4%患者反流完全消除且症状改善。
  • 55例(22.0%)随访期间因膝下大隐静脉残余反流需计划性二次治疗。
  • 轻微不良事件包括无症状深静脉血栓2例、股总静脉血栓延伸1例、浅静脉血栓4例。

核心结论

  • 逆行给予1%聚多卡醇微泡沫是安全有效的治疗,对社区实践中的浅表静脉功能不全具有重要临床获益。

研究设计与样本

  • 研究于2015年3月至2017年6月在社区环境中纳入250例C2-C6慢性静脉功能不全的症状性患者,接受1%聚多卡醇微泡沫治疗并随访16±7个月。
  • 250例中16例(6.4%)有皮肤溃疡,56例(22.4%)既往接受过热力或手术干预。
  • 所有患者均行双功能超声静脉功能不全检查以标测穿通支和待治疗静脉。

主要发现

  • 所有患者完成初始治疗;55例(22.0%)在随访期间因膝下大隐静脉残余静脉反流需要计划性二次治疗。
  • 236例(94.4%)记录到静脉瓣膜反流完全消除和症状改善。
  • 轻微不良事件包括无症状深静脉血栓(n=2)、股总静脉血栓延伸(n=1)和浅静脉血栓(n=4)。
  • 16例皮肤溃疡患者中10例为C6级,80%在治疗后4周内创面愈合。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study measured patient outcomes among symptomatic patients with superficial chronic venous insufficiency who were treated with retrograde ultrasound-guided polidocanol microfoam 1% in a community setting. METHODS: Between March 2015 and June 2017, 250 symptomatic patients with C2-C6 chronic venous insufficiency received polidocanol microfoam 1% and were followed for 16 ± 7 months. Sixteen of the 250 patients (6.4%) had skin ulcers, and 56 (22.4%) were treated previously with thermal or surgical interventions. All patients underwent a duplex ultrasound venous incompetence study to map perforators and veins to be treated. Incompetent veins were accessed with a micropuncture needle distal to the midthigh perforator, approximately 10 cm above the knee fold. The leg was then elevated 45°. Under ultrasound guidance, the incompetent greater saphenous vein was closed with polidocanol microfoam 1%. A second injection was administered through the same catheter directing the microfoam to flow in a retrograde fashion through the incompetent venous valves to the ankle. RESULTS: All patients completed the initial treatment; 55 (22.0%) required planned secondary treatment during the follow-up period for residual venous reflux in the below-knee greater saphenous vein. Complete elimination of venous valvular reflux and symptom improvement was documented in 236 patients (94.4%). Minor adverse events included asymptomatic deep vein thrombi (n = 2), common femoral vein thrombus extension (n = 1), and superficial venous thrombi (n = 4). Of the 16 patients with skin ulcers, 10 were C6 patients and 80% experienced wound closure within 4 weeks of treatment. CONCLUSIONS: Retrograde administration of polidocanol microfoam 1% is a safe and effective treatment with important clinical benefit for superficial venous insufficiency in community practice.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Deak ST. Retrograde administration of ultrasound-guided endovenous microfoam chemical ablation for the treatment of superficial venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29909854. doi:10.1016/j.jvsv.2018.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。